|
CPEB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63147273468667E-12 |
| Normal-vs-Stage2 |
4.05070000000229E-05 |
| Normal-vs-Stage3 |
6.16090001237524E-09 |
| Normal-vs-Stage4 |
5.90609999999714E-05 |
| Stage1-vs-Stage2 |
2.582800E-01 |
| Stage1-vs-Stage3 |
6.471400E-01 |
| Stage1-vs-Stage4 |
5.062000E-02 |
| Stage2-vs-Stage3 |
1.865410E-01 |
| Stage2-vs-Stage4 |
3.822000E-02 |
| Stage3-vs-Stage4 |
1.977990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.19759999999991E-05 |
| Normal-vs-Asian |
1.414160E-01 |
| Caucasian-vs-AfricanAmerican |
2.684100E-02 |
| Caucasian-vs-Asian |
5.741400E-01 |
| AfricanAmerican-vs-Asian |
9.792800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.2492901398723E-12 |
| Normal-vs-Female |
1.62481139653892E-12 |
| Male-vs-Female |
5.204700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.134200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.4033219031262E-13 |
| Normal-vs-Age(61-80Yrs) |
1.7981172106829E-12 |
| Normal-vs-Age(81-100Yrs) |
4.118300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.789700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.386700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.178100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.696000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.599400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.588400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.942700E-03 |
| Normal-vs-Grade 2 |
6.70574706873595E-14 |
| Normal-vs-Grade 3 |
1.75137682134618E-12 |
| Normal-vs-Grade 4 |
3.940800E-03 |
| Grade 1-vs-Grade 2 |
8.190200E-01 |
| Grade 1-vs-Grade 3 |
6.623600E-01 |
| Grade 1-vs-Grade 4 |
6.455500E-03 |
| Grade 2-vs-Grade 3 |
6.440800E-01 |
| Grade 2-vs-Grade 4 |
2.12399999999224E-05 |
| Grade 3-vs-Grade 4 |
7.63639999999954E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.91559999979307E-07 |
| ccA subtype-vs-ccB subtype |
1.20820000004684E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94289029309402E-14 |
| Normal-vs-N1 |
8.452400E-02 |
| N0-vs-N1 |
3.174200E-01 |
|
|
